New: Biosimilars strategies introduced.
Close
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
April 19, 2023 - Wilshire launched an authorized brand alternative of Azurity’s Fleqsuvy (baclofen) oral suspension.
Download PDF
Return to publications
